Associated Papers
Derivation of Genetically Defined Murine Hepatoblastoma Cell Lines with Angiogenic Potential.
Chen K et al.
Cancers, 2025
Specific cancer types and prognosis in patients with variations in the KEAP1-NRF2 system: A retrospective cohort study.
Iwasaki T et al.
Cancer Science, 2024
Organismal metabolism regulates the expansion of oncogenic PIK3CA mutant clones in normal esophagus.
Herms A et al.
Nature Genetics, 2024
39169259 (PubMed )
Supplement: 41588_2024_1891_MOESM6_ESM.xlsx › Fig_1a
Nrf2, A Target for Precision Oncology in Cancer Prognosis and Treatment.
Ngo HKC et al.
Journal of Cancer Prevention, 2023
HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells.
Woodfield SE et al.
Biology Open, 2022
NRF2 DLG Domain Mutations Identified in Japanese Liver Cancer Patients Affect the Transcriptional Activity in HCC Cell Lines.
Haque E et al.
International Journal of Molecular Sciences, 2021
Reconciling the Biological and Transcriptional Variability of Hepatoblastoma with Its Mutational Uniformity.
Prochownik EV
Cancers, 2021
Patient-Derived Mutant Forms of NFE2L2/NRF2 Drive Aggressive Murine Hepatoblastomas.
Wang H et al.
Cellular and Molecular Gastroenterology and Hepatology, 2021
Comprehensive targeted super-deep next generation sequencing enhances differential diagnosis of solitary pulmonary nodules.
Ye M et al.
Journal of Thoracic Disease, 2018
Functional polymorphisms in Nrf2: implications for human disease.
Cho HY et al.
Free Radical Biology & Medicine, 2015
The genomic landscape of hepatoblastoma and their progenies with HCC-like features.
Eichenmüller M et al.
Journal of Hepatology, 2014
Select a paper to view details